Literature DB >> 22543057

Biospecimen reporting for improved study quality (BRISQ).

Helen M Moore, Andrea Kelly, Lisa M McShane, Jim Vaught.   

Abstract

Mesh：

Year:  2012        PMID： 22543057     DOI： 10.1016/j.cca.2012.04.013

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN： 0009-8981            Impact factor:   3.786


× No keyword cloud information.
  6 in total

1.  National Cancer Institute Biospecimen Evidence-Based Practices: a novel approach to pre-analytical standardization.

Authors:  Kelly B Engel; Jim Vaught; Helen M Moore
Journal:  Biopreserv Biobank       Date:  2014-04       Impact factor: 2.300

Review 2.  Biomarker validation and testing.

Authors:  Daniel F Hayes
Journal:  Mol Oncol       Date:  2014-10-18       Impact factor: 6.603

Review 3.  A critical analysis of cancer biobank practices in relation to biospecimen quality.

Authors:  Amanda Rush; Kevin Spring; Jennifer A Byrne
Journal:  Biophys Rev       Date:  2015-10-22

4.  Biospecimens and Molecular and Cellular Biomarkers in Aneurysmal Subarachnoid Hemorrhage Studies: Common Data Elements and Standard Reporting Recommendations.

Authors:  Sherry H-Y Chou; R Loch Macdonald; Emanuela Keller
Journal:  Neurocrit Care       Date:  2019-06       Impact factor: 3.210

5.  OMICS-based personalized oncology: if it is worth doing, it is worth doing well!

Authors:  Daniel F Hayes
Journal:  BMC Med       Date:  2013-10-17       Impact factor: 8.775

6.  Intrauterine Growth Restriction Alters Mouse Intestinal Architecture during Development.

Authors:  Camille M Fung; Jessica R White; Ashley S Brown; Huiyu Gong; Jörn-Hendrik Weitkamp; Mark R Frey; Steven J McElroy
Journal:  PLoS One       Date:  2016-01-08       Impact factor: 3.240
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.